SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000893220-06-001847
Filing Date
2006-08-11
Accepted
2006-08-11 15:51:33
Documents
5
Period of Report
2006-07-02

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q PAR PHARMACEUTICAL COMPANIES, INC w24133qe10vq.htm 10-Q 73812
2 CERTIFICATION OF THE PRINCIPAL EXECUTIVE OFFICER w24133qexv31w1.htm EX-31.1 1206
3 CERTIFICATION OF THE PRINCIPAL FINANCIAL OFFICER w24133qexv31w2.htm EX-31.2 1208
4 CERTIFICATION OF THE PRESIDENT AND CHEIF EXECUTIVE OFFICER PURSUANT TO SECTION 9 w24133qexv32w1.htm EX-32.1 1358
5 CERTIFICATION OF THE CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 906 w24133qexv32w2.htm EX-32.2 1332
  Complete submission text file 0000893220-06-001847.txt   80427
Mailing Address 300 TICE BOULEVARD WOODCLIFF LAKE NJ 07677
Business Address 300 TICE BOULEVARD WOODCLIFF LAKE NJ 07677 845-425-7100
PAR PHARMACEUTICAL COMPANIES, INC. (Filer) CIK: 0000878088 (see all company filings)

IRS No.: 223122182 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-10827 | Film No.: 061024990
SIC: 2834 Pharmaceutical Preparations